Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
6.83
+0.13 (1.94%)
At close: Apr 17, 2025, 4:00 PM
6.85
+0.02 (0.29%)
Pre-market: Apr 21, 2025, 7:02 AM EDT

Amicus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2,0982,8154,1613,4303,2186,017
Upgrade
Market Cap Growth
-32.36%-32.36%21.31%6.59%-46.51%142.44%
Upgrade
Enterprise Value
2,2923,0104,3353,5273,1015,948
Upgrade
Last Close Price
6.839.4214.1912.2111.5523.09
Upgrade
Forward PE
282.2387.63----
Upgrade
PS Ratio
3.945.3310.4210.4210.5323.06
Upgrade
PB Ratio
10.5314.5125.9827.8810.4721.01
Upgrade
P/TBV Ratio
----29.3767.93
Upgrade
EV/Sales Ratio
4.345.7010.8610.7110.1522.80
Upgrade
EV/EBITDA Ratio
53.7970.63----
Upgrade
EV/EBIT Ratio
67.2988.35----
Upgrade
Debt / Equity Ratio
2.292.292.783.671.431.54
Upgrade
Debt / EBITDA Ratio
8.618.61----
Upgrade
Asset Turnover
0.680.680.530.400.340.30
Upgrade
Inventory Turnover
0.590.590.891.531.491.85
Upgrade
Quick Ratio
2.362.362.232.593.674.09
Upgrade
Current Ratio
3.393.392.883.054.094.47
Upgrade
Return on Equity (ROE)
-31.68%-31.68%-107.04%-109.93%-84.37%-72.59%
Upgrade
Return on Assets (ROA)
2.72%2.72%-6.12%-15.68%-13.95%-17.55%
Upgrade
Return on Capital (ROIC)
3.43%3.43%-7.78%-19.32%-16.93%-21.55%
Upgrade
Return on Capital Employed (ROCE)
5.40%5.40%----
Upgrade
Earnings Yield
-2.67%-1.99%-3.64%-6.90%-7.78%-4.60%
Upgrade
FCF Yield
-1.78%-1.33%-1.84%-4.97%-6.41%-3.93%
Upgrade
Buyback Yield / Dilution
-3.12%-3.12%-2.11%-6.50%-4.85%-7.67%
Upgrade
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q